🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In order to assess the potential impact of steady state BI 425809 on CYP3A ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-03-18
Trial ID
NCT05258110
Treatments Being Tested
The main objective of this trial is to investigate the relative bioavailabi...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2019-02-11
Trial ID
NCT03817476
Treatments Being Tested
The main objective of this trial is to investigate the possible effect of m...
Status
Completed
Location
CRS Clinical Research Services Mannheim GmbH
Start Date
2022-11-24
Trial ID
NCT05613777
Treatments Being Tested
The main objective of this trial is to investigate the potential effect of ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-10-25
Trial ID
NCT05347004
Treatments Being Tested
The study is designed to compare the effects of BI 425809 compared to place...
Status
Completed
Location
Axiom Research LLC
Start Date
2016-08-11
Trial ID
NCT02788513
Treatments Being Tested
The primary objective of this trial is to investigate the relative bioavail...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-03-28
Trial ID
NCT03082183
Treatments Being Tested
The main objective of this trial is to investigate the relative bioavailabi...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2023-03-06
Trial ID
NCT05723874
The objective of the study is to investigate the efficacy, safety and pharm...
Status
Completed
Location
Collaborative Neuroscience Network, LLC (CNS)
Start Date
2016-07-25
Trial ID
NCT02832037
Treatments Being Tested
To investigate the safety, tolerability and pharmacokinetics of BI 425809 t...
Status
Completed
Location
1346.4.82001 Boehringer Ingelheim Investigational Site
Start Date
2015-05-11
Trial ID
NCT02383888
The main objective of this trial is to investigate the effect of fluconazol...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2021-10-19
Trial ID
NCT05076409
Treatments Being Tested